22 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Farnesyl diphosphate synthase inhibitors with unique ligand-binding geometries.
University of Illinois At Urbana-Champaign
Multitarget drug discovery for tuberculosis and other infectious diseases.
University of Illinois At Urbana-Champaign
A quantitative structure-activity relationship and pharmacophore modeling investigation of aryl-X and heterocyclic bisphosphonates as bone resorption agents.
University of Illinois At Urbana-Champaign
Head-to-head prenyl tranferases: anti-infective drug targets.
University of Illinois At Urbana-Champaign
Bisphosphonate inhibition of the exopolyphosphatase activity of the Trypanosoma brucei soluble vacuolar pyrophosphatase.
University of Illinois At Urbana-Champaign
Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorption.
University of Illinois At Urbana-Champaign
Steroidal bivalent ligands for the estrogen receptor: design, synthesis, characterization and binding affinities.
University of Illinois At Urbana-Champaign
Phosphonosulfonates are potent, selective inhibitors of dehydrosqualene synthase and staphyloxanthin biosynthesis in Staphylococcus aureus.
University of Illinois At Urbana-Champaign
Inhibition of staphyloxanthin virulence factor biosynthesis in Staphylococcus aureus: in vitro, in vivo, and crystallographic results.
University of Illinois At Urbana-Champaign
Synthesis and biological evaluation of guanylhydrazone coactivator binding inhibitors for the estrogen receptor.
University of Illinois At Urbana-Champaign
Bisphosphonate inhibitors of ATP-mediated HIV-1 reverse transcriptase catalyzed excision of chain-terminating 3'-azido, 3'-deoxythymidine: a QSAR investigation.
University of Illinois At Urbana-Champaign
Blocking estrogen signaling after the hormone: pyrimidine-core inhibitors of estrogen receptor-coactivator binding.
University of Illinois At Urbana-Champaign
Activity of sulfonium bisphosphonates on tumor cell lines.
University of Illinois At Urbana-Champaign
Investigation into the Mechanism of Action of the Tuberculosis Drug Candidate SQ109 and Its Metabolites and Analogues in Mycobacteria.
University of Illinois At Urbana-Champaign
Inhibition of Trypanosoma cruzi hexokinase by bisphosphonates.
University of Illinois At Urbana-Champaign
A chemical strategy to promote helical peptide-protein interactions involved in apoptosis.
University of Illinois At Urbana-Champaign
Effects of bisphosphonates on the growth of Entamoeba histolytica and Plasmodium species in vitro and in vivo.
University of Illinois At Urbana-Champaign
3-D QSAR investigations of the inhibition of Leishmania major farnesyl pyrophosphate synthase by bisphosphonates.
University of Illinois At Urbana-Champaign
Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates and diphosphates: a potential route to new bone antiresorption and antiparasitic agents.
University of Illinois At Urbana-Champaign
Inhibition of the Fe(4)S(4)-cluster-containing protein IspH (LytB): electron paramagnetic resonance, metallacycles, and mechanisms.
University of Illinois At Urbana-Champaign
3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds
Hoffmann-La Roche